Tag: Ketamine
Ketamine Augmentation of Exposure Response Prevention Therapy for Obsessive-compulsive Disorder
by Hugo Bottemanne, MD, and Alice Arnould, MSc Dr. Bottemanne and Ms. Arnould are with Sorbonne University, Paris Brain Institute–Institut du Cerveau (ICM), and Department of Psychiatry (Pitié-Salpêtrière Hospital, APHP) in Paris, France. FUNDING: No funding was provided for this study. DISCLOSURES: The author has no conflicts of interest relevant to the content of this […]
Ketamine Therapy for Treatment-resistant Depression in a Patient with Multiple Sclerosis: A Case Report
by Michael M. Messer, MD, and Irina V. Haller, PhD, MS Dr. Messer is with Behavioral Health Department, Essentia Health, Duluth, MN, and Dr. Haller is with Essentia Institute of Rural Health, Essentia Health, Duluth, MN, USA. Innov Clin Neurosci. 2017;14(1–2):56–59. Funding: This research had no grant funding from any funding agency in the public, […]
The Neuroscience Report—Vol. 39 (April 11, 2016): Rapid-acting Antidepressants
The latest in neuroscience—sorted and summarized for you Welcome to The Neuroscience Report where each week we will highlight a specific topic in neuroscience and provide you with links to 5 journal articles, 5 news articles, and 5 wildcard picks. Brought to you by Innovations in Clinical Neuroscience—your source for peer-reviewed, evidence-based information. This week’s […]
Use of Ketamine in Acute Cases of Suicidality
by Jae Lee, DO; Puneet Narang, MD; Manasa Enja, MD; and Steven Lippmann, MD Dr. Lee is resident physician at Hennepin-Regions Psychiatry Program, Minneapolis-St. Paul, Minnesota; Dr. Narang is staff physician and ECT psychiatrist, Regions Hospital, Minneapolis-St. Paul, Minnesota; Dr. Enja is observer physician, University of Louisville School of Medicine, Louisville, Kentucky; and Dr. Lippmann is […]
